- ICH GCP
- EU klinikai vizsgálatok nyilvántartása
Legfrissebb próbák
EudraCT Number: 2004-001600-12 | Sponsor Protocol Number: F/2004/2. | Start Date: 2004-09-20 | ||||||
Sponsor Name: OMNINVEST Kft. | ||||||||
Full Title: Fluval AB Vaccine Serologic Clinical Trial | ||||||||
Medical condition: Immunization of healthy people against influenza virus infections. | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: HU (Completed) | ||||||||
Trial results: View results |
EudraCT Number: 2004-000838-36 | Sponsor Protocol Number: PX104.1.7-201 | Start Date: 2004-09-20 | ||||||
Sponsor Name: Pharmexa A/S | ||||||||
Full Title: A Phase II trial evaluating the immunological and clinical efficay and safety of HER-2 Protein Autovac(TM) monotherapy in patients with metastatic breast cancer | ||||||||
Medical condition: Female patients with histologically proven metastatic or locally advanced breast cancer who have HER-2 overexpression in the primary tumour and/or a metastatic lesion. | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Female | |||||||
Trial protocol: HU (Completed) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2004-000083-27 | Sponsor Protocol Number: GT-08 | Start Date: 2004-09-19 | ||||||
Sponsor Name: ALK-Abelló A/S | ||||||||
Full Title: A randomised, parallel-group, double-blind, placebo-controlled Phase III trial assessing the efficacy and safety of ALK Grass Tablet Phleum pratense in subjects with seasonal grass pollen induced r... | ||||||||
Medical condition: Rhinoconjunctivitis | ||||||||
|
||||||||
Population Age: Adults | Gender: Male, Female | |||||||
Trial protocol: SE (Completed) IT (Completed) ES (Completed) AT (Completed) GB (Completed) | ||||||||
Trial results: View results |
EudraCT Number: 2004-000091-14 | Sponsor Protocol Number: FFR102123 | Start Date: 2004-09-17 | ||||||
Sponsor Name: GlaxoSmithKline, S.A | ||||||||
Full Title: A Randomised, Double-Blind, Placebo-Controlled, Parallel Group, Multicentre, Long-Term Study to Evaluate the Safety of Once-Daily, Intranasal Administration of GW685698X Aqueous Nasal Spray 100mcg ... | ||||||||
Medical condition: Perennial allergic rhinitis | ||||||||
|
||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: ES (Completed) SE (Completed) LV (Completed) LT (Completed) IT (Completed) | ||||||||
Trial results: View results |
EudraCT Number: 2004-002137-39 | Sponsor Protocol Number: V1 25/07/04 | Start Date: 2004-09-17 | ||||||
Sponsor Name: | ||||||||
Full Title: A randomised controlled trial of the combined use of paracetamol and ibuprofen to treat febrile children | ||||||||
Medical condition: Fevers in childhood not asscoaited with severe disease in the immunocompenetent or fever in the immunocompromised host. | ||||||||
|
||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2004-001347-29 | Sponsor Protocol Number: | Start Date: 2004-09-17 | |||||||||||
Sponsor Name: Odense University Hospital | |||||||||||||
Full Title: Treatment of patients with locally advanced rectal cancer. TEGAFOX (UFT/leukovorin og Oxaliplatin) before, during and after curatively intended radiotherapy. A Danish phase I/II trial | |||||||||||||
Medical condition: Locally advanced non-resectable rectal cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-003701-91 | Sponsor Protocol Number: INT 27/04 | Start Date: 2004-09-17 | |||||||||||
Sponsor Name: ISTITUTO NAZIONALE PER LA CURA TUMORI | |||||||||||||
Full Title: ONCE WEEKLY DOSING OF DARBEPOETIN ALPHA AS PROPHYLACTIC TREATMENT FOR ANEMIA IN ELDERLY CANCER PATIENTS | |||||||||||||
Medical condition: ELDERLY PATIENTS WITH GASTROINTESTINAL AND LUNG CANCER | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-000850-22 | Sponsor Protocol Number: 044(2A)SC04030 | Start Date: 2004-09-17 | |||||||||||
Sponsor Name: ANGELINI | |||||||||||||
Full Title: Evaluation of tolerability and analgesic activity of paracetamol 1000 mg+caffeine 130 mg in the treatment of tension-type headache. Randomized, double blind, double-dummy, cross-over study vs. napr... | |||||||||||||
Medical condition: Evaluation of tolerability and analgesic activity in the treatment of tension-type headache | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-000137-11 | Sponsor Protocol Number: EMR62202-013 | Start Date: 2004-09-17 | |||||||||||
Sponsor Name: Merck KGaA | |||||||||||||
Full Title: Open, randomized, controlled, multicenter phase III study comparing 5-FU/FA plus irinotecan plus cetuximab versus 5-FU/FA plus irinotecan as first-line treatment for epidermal growth factor recepto... | |||||||||||||
Medical condition: First-line treatment for epidermal growth factor receptor-expressing metastatic colorectal cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) CZ (Completed) SK (Completed) SE (Completed) FI (Completed) IT (Completed) LT (Completed) EE (Completed) GB (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-001075-20 | Sponsor Protocol Number: FG-506-17-04 | Start Date: 2004-09-16 | |||||||||||
Sponsor Name: Fujisawa GmbH | |||||||||||||
Full Title: A MULTICENTER, RANDOMIZED, DOUBLE BLIND, DOUBLE-DUMMY PLACEBO- CONTROLLED PARALLEL-GROUP MULTIPLE DOSE STUDY OF THE EFFICACY AND SAFETY OF TACROLIMUS INHALATION AEROSOL IN PATIENTS WITH MODERATE P... | |||||||||||||
Medical condition: Moderate persistent asthma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: LT (Completed) | |||||||||||||
Trial results: View results |